Edgar Engleman
4 additional roles and seats, 4 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days.
Roles
- Vivo Capital, LLC Managing PartnerJun 1, 2005 to present · “Schedule A: ENGLEMAN, EDGAR, GEORGE, MANAGING PARTNER, since 06/2005, ownership B, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Bolt Biotherapeutics | Form D equity offering · $15.0M | Vivo Capital, LLC | strongly supported · board | Jun 7, 2021 | Inference sec.gov |
| Bolt Biotherapeutics | Form D equity offering · $93.5M | Vivo Capital, LLC | strongly supported · board | Jan 28, 2021 | Inference sec.gov |
| Bolt Biotherapeutics | Form D equity offering · $40.1M | Vivo Capital, LLC | strongly supported · board | Jul 15, 2019 | Inference sec.gov |
Board seats and vehicles
- Bolt Biotherapeutics board seat on a deal Jun 7, 2021 Inference
- Soleno Therapeutics Inc board seat on a deal Feb 24, 2010 Inference
- Vivo Ventures Fund VII, LP Director Jan 3, 2011
- Vivo Ventures VII Affiliates Fund, LP Director Jan 3, 2012
- Vivo Capital Fund Viii, L.P. Director Dec 18, 2014
Timeline
- Jun 7, 2021Form D equity offering in Bolt Biotherapeutics (Vivo Capital, LLC)
- Jan 28, 2021Form D equity offering in Bolt Biotherapeutics (Vivo Capital, LLC)
- Jul 15, 2019Form D equity offering in Bolt Biotherapeutics (Vivo Capital, LLC)
- Jun 1, 2005Joined Vivo Capital, LLC as Managing Partner
Relationships across DFX
on 2 other DFX graphs
Edgar Engleman is the same institution as 3 records in Private Equity and Independent Sponsors.
DFX found 3 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…